EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Impact of Obesity on Atrial Fibrillation Pathogenesis and Treatment Options

Rina Sha iD, Olivia Baines iD, Abbie Hayes, Katie Tompkins iD, Manish Kalla iD, Andrew P Holmes iD, Christopher O'Shea iD, Davor Pavlovic iD

Journal of the American Heart Association · 02.01.2024 · 13 (1)

DOI: 10.1161/jaha.123.032277 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of the American Heart Association, erschienen am 02.01.2024. Verfasst von Rina Sha und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cardiovascular Sciences, University of Birmingham Birmingham United Kingdom. Hauptthemen laut MEDLINE: Atrial Fibrillation, Heart Failure. Die Arbeit wurde bisher 142-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: British Heart Foundation, Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atrial fibrillation (AF) is the most common cardiac arrhythmia. AF increases the risk of stroke, heart failure, dementia, and hospitalization. Obesity significantly increases AF risk, both directly and indirectly, through related conditions, like hypertension, diabetes, and heart failure. Obesity‐driven structural and electrical remodeling contribute to AF via several reported mechanisms, including adiposity, inflammation, fibrosis, oxidative stress, ion channel alterations, and autonomic dysfunction. In particular, expanding epicardial adipose tissue during obesity has been suggested as a key driver of AF via paracrine signaling and direct infiltration. Weight loss has been shown to reverse these changes and reduce AF risk and recurrence after ablation. However, studies on how obesity affects pharmacologic or interventional AF treatments are limited. In this review, we discuss mechanisms by which obesity mediates AF and treatment outcomes, aiming to provide insight into obesity‐drug interactions and guide personalized treatment for this patient subgroup.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationHeart FailureHumansObesityTreatment OutcomeAdiposity

Stichwörter der Autor:innen

antiarrhythmic drugsatrial fibrillationepicardial adipose tissueion channelobesity

Autor:innen und Institutionen

  • Institute of Cardiovascular Sciences, University of Birmingham Birmingham United Kingdom.

ORCID-Profile: Rina Sha, Olivia Baines, Katie Tompkins, Manish Kalla, Andrew P Holmes, Christopher O'Shea, Davor Pavlovic

Förderung

  • British Heart Foundation
  • Wellcome Trust

Zitieren

APA

Sha, R., Baines, O., Hayes, A., Tompkins, K., Kalla, M., Holmes, A. P., O'Shea, C., & Pavlovic, D. (2024). Impact of Obesity on Atrial Fibrillation Pathogenesis and Treatment Options. Journal of the American Heart Association, 13(1). https://doi.org/10.1161/jaha.123.032277

Vancouver

Sha R, Baines O, Hayes A, Tompkins K, Kalla M, Holmes AP, et al. Impact of Obesity on Atrial Fibrillation Pathogenesis and Treatment Options. Journal of the American Heart Association. 2024;13(1). doi:10.1161/jaha.123.032277

BibTeX
@article{Sha2024,
  author = {Sha, Rina and Baines, Olivia and Hayes, Abbie and Tompkins, Katie and Kalla, Manish and Holmes, Andrew P and O'Shea, Christopher and Pavlovic, Davor},
  title = {Impact of Obesity on Atrial Fibrillation Pathogenesis and Treatment Options},
  journal = {Journal of the American Heart Association},
  year = {2024},
  volume = {13},
  number = {1},
  doi = {10.1161/jaha.123.032277}
}
Kostenlos starten →